ISPR at a glance
Ispire Technology Inc. (ISPR, SEC CIK 1948455) filed its latest 10-K annual report on September 15, 2026, a 10-Q quarterly report on May 7, 2026, an 8-K current report on September 23, 2026 and Form 4 insider filings as recently as August 14, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended June 30, 2026 (FY2026), Ispire Technology Inc. (ISPR) reported revenue of $96.0 million (down 24.7% from FY2025) and a net loss of $33.2 million. Diluted EPS was -$0.58.
- As of June 30, 2026, 13 institutional investment managers tracked by SignalX reported holding Ispire Technology Inc. (ISPR) shares worth $1.4 million in 13F-HR filings.
- The most recent insider open-market purchase reported on Form 4 was by Wang Michael Xue on March 2, 2026 of 100 shares at $2.38 per share.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2026
- $96.0M
- −24.7% vs prior year
- Insiders · 90 days
- 0 buys · 0 sells
- No open-market trades
- 13F holders
- 13 funds
- $1.4M · −3 vs prior quarter
- Latest 8-K
- Sep 23, 2026
- Item 7.01
AI 10-K Annual Report Analysis
Latest 10-K, fiscal year ended Jun 30, 2026
Risk Factors
- Regulatory risk: FDA PMTA compliance and enforcement for nicotine ENDS under Family Smoking Prevention and Tobacco Control Act; costly $1M+ per PMTA application
- Geopolitical risk: U.S. tariffs on Chinese imports at 35% and Malaysian imports at 19%, affecting Shenzhen Yi Jia product costs, a major supplier
- Operational risk: Dependence on Shenzhen Yi Jia (95% owned by CEO) for manufacturing; risks in scaling new Malaysian facility and controlling quality
- Competitive risk: Pressure from largest producer Smoore International Holdings Limited and technological innovation demands in vaping market
- Financial risk: Majority stock ownership and supplier control by CEO Tuanfang Liu pose conflicts of interest impacting pricing and governance
Business Overview
- Core business: design, R&D, commercialization, sales of vaping hardware for nicotine and cannabis under Aspire and Ispire brands globally
- New products: proprietary Ispire ONE™ technology introduced June 2023; development started on G-Mesh porous glass coil tech marketed as “Silica Series”
- Strategic shift: major expansion of owned manufacturing in Malaysia, commenced in Feb 2024 with 6 lines, aiming to add 70 new lines over next 12 months
- Quantitative highlights: revenue declined 25% to $96M in 2026 from $127M in 2025; OEM/ODM share rose to 44.5% of e-cigarette revenue in 2026 from 40.2% in 2025; employee count 88 as of Sept 2026
- Noteworthy fact: Formation and FDA engagement of IKE joint venture with 40% ownership to develop age-gating tech for e-cigarettes, including PMTA submissions and recent FDA draft guidance linking DAR tech to flavored ENDS authorization
Management Discussion & Analysis
- Revenue $96.0M, down 24.7% YoY from $127.5M; US sales fell $17.4M, Europe down $12.7M due to regulatory challenges
- Gross margin 12.8% vs 17.8% prior year; gross profit $12.3M vs $22.6M, margin decline due to pricing pressure, lower cannabis product mix, and $2.8M inventory write-down
- Europe segment best performer with $61.4M revenue (63.9%), North America weakest at $15.1M (15.8%) reflecting tightening sales strategy
- Operating expenses down 25.8% to $44.9M driven by cuts in marketing (-40.5%) and G&A (-36.2%); net loss improved to $33.2M from $39.2M, loss per share $0.58 vs $0.69
- Operating cash flow usage reduced to $0.6M vs $7.4M; invested $3.1M mainly in joint venture and capex; $1.3M repaid on borrowings; management expects current cash and operations to fund next 12 months but additional financing may be needed if growth accelerates or conditions worsen
AI summary of the ISPR 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Mar 31, 2026
Management Discussion & Analysis
- Quarterly revenue, YoY change, and profitability percentages not provided in supplied MD&A
- Malaysia nicotine manufacturing license secured March 17, 2026
- Malaysia nicotine production expected to commence end of June 2026
- Operating cash flow improvement expected during 2026
- Positive cash flow targeted in first half of fiscal 2027, subject to execution and market conditions
Risk Factors
- Negative cash flows remain material, with positive cash flow targeted for the first half of fiscal 2027
- China nicotine-vapor policies, global trade policy, and Malaysian supply-chain partnerships could delay cash-flow improvement
- IKE’s FDA component PMTA, submitted April 2025 after a November 13, 2024 FDA meeting, may fail
- Joint-venture financing could dilute Ispire’s 40% IKE and 49% Jin Wu ownership interests
- Ispire had $8,839,130 invested in and advanced to IKE as of March 31, 2026
AI summary of the ISPR 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 7.01: Regulation FD Disclosure
- Exhibit 99.1 excluded from Exchange Act Section 18 “filed” status, limiting liability exposure
- Exhibit not incorporated into Securities Act or Exchange Act filings unless expressly referenced
Item EX-99.1: Item EX-99.1
- Investor presentation highlights $96M TTM revenue, with e-cigarettes representing 84% as of June 30, 2026
- Q4 FY2026 revenue reached $26.7M, up 33% year over year from $20.1M
Item 2.02: Results of Operations and Financial Condition
- Filing references Exhibits 99.1 and 99.2 as accompanying earnings materials
- Exhibits excluded from Exchange Act Section 18 “filed” status and related liability
Item EX-99.1: Item EX-99.1
- Q4 revenue $26.7M, up 32.5% YoY and 43% sequentially, signaling a meaningful operational rebound
- FY2026 revenue fell 24.7% to $96.0M, driven by U.S. cannabis hardware and European vaping declines
Item 7.01: Regulation FD Disclosure
- No substantive Regulation FD disclosure appears in the provided excerpt
- Excerpt contains boilerplate Exchange Act incorporation language, not company-specific operating or financial information
Item EX-99.1: Item EX-99.1
- Steven Przybyla appointed President effective immediately while retaining Chief Legal Officer and Secretary roles
- Expanded mandate includes investor communications, regulatory strategy, growth plans and IKE Tech joint venture messaging
Item 5.02: Departure/Appointment of Directors or Principal Officers
- Steven Przybyla appointed President effective August 11, 2026, while retaining Chief Legal Officer and Secretary roles
- Leadership consolidation adds regulated cannabis and nicotine/tobacco expertise to the company’s executive leadership
AI summaries of ISPR 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for ISPR
Don't miss the next ISPR filing
- Alerts as it files. A push when ISPR files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut ISPR, by share count.
- Ask anything. An AI agent that reads every ISPR filing and answers with sources.
ISPR alerts on your phone. Follow it in the SignalX Android app.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| Cox Brent | A | Aug 14, 2026 | 53,555 | - |
| Burch Christopher Robert | A | Aug 14, 2026 | 45,760 | - |
| Fargis John | A | Aug 14, 2026 | 45,760 | - |
| Burch Christopher Robert | A | Mar 19, 2026 | 35,526 | - |
| Fargis John | A | Mar 19, 2026 | 35,526 | - |
| Cox Brent | A | Mar 19, 2026 | 35,526 | - |
| Wang Michael Xue | Buy | Mar 2, 2026 | 100 | $2.38 |
| Wang Michael Xue | Buy | Mar 2, 2026 | 1,163 | $2.41 |
Financial SummaryXBRL
| Metric | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
| Profitability | |||
| Revenue | - | $127.5M | $96.0M |
| Gross Profit | - | $22.6M | $12.3M |
| Operating Income | - | -$37.8M | -$32.6M |
| Net Income | - | -$39.2M | -$33.2M |
| Gross Margin | - | 17.8% | 12.8% |
| Op. Margin | - | -29.7% | -33.9% |
| Net Margin | - | -30.8% | -34.6% |
| Balance Sheet | |||
| Total Assets | $122.6M | $102.2M | $64.3M |
| Equity | $34.5M | $605K | -$29.2M |
| ROE | - | -6489.3% | 113.5% |
| Per Share | |||
| EPS | - | $-0.69 | $-0.58 |
| Cash Flow | |||
| Operating CF | - | -$7.4M | -$569K |
| CapEx | - | $1.1M | $306K |
Source: XBRL data in Ispire Technology Inc. (ISPR)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q2 2026Aggregate ISPR share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q2 2026 | 13 | $1.4M |
| Q1 2026 | 16 | $4.4M |
| Q4 2025 | 16 | $7.1M |
| Q3 2025 | 15 | $6.5M |
| Q2 2025 | 15 | $6.5M |
| Q1 2025 | 11 | $3.0M |
| Q4 2024 | 7 | $5.0M |
| Q3 2024 | 5 | $2.8M |
- Goldman Sachs Group+76.2K (+113%)
- AQR Capital Management+53.7K (+103%)
- Renaissance Technologies LLC+600 (+5%)
- PNC Financial Services+383 (+246%)
- BlackRock−846.7K (-67%)
- State Street Corp−279.8K (-81%)
- Northern Trust−106.3K (-70%)
- Morgan Stanley−36.4K (-47%)
- JPMorgan Chase & Co−7.7K (-95%)
- Millennium Management+260.0K
- Vanguard Portfolio Management LLC−112.7K
- BNY Mellon−55.4K
- Bank of America Corp−17.7K
- Wells Fargo & Co−6.8K
Source: 13F-HR filings on SEC EDGAR (aggregated from 98 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
ISPR filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
10-K annual reports
10-Q quarterly reports
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 8-K | Sep 23, 2026 | - | Analysis | - |
| 8-K | Sep 17, 2026 | - | Analysis | - |
| 10-K | Sep 15, 2026 | Jun 30, 2026 | Analysis | |
| 8-K | Aug 17, 2026 | - | Analysis | - |
| 4 | Aug 14, 2026 | - | - | - |
| 4 | Aug 14, 2026 | - | - | - |
| 4 | Aug 14, 2026 | - | - | - |
| 8-K | Jul 17, 2026 | - | Analysis | - |
| 8-K | Jun 25, 2026 | - | Analysis | - |
| 10-Q | May 7, 2026 | Mar 31, 2026 | Analysis | |
| 4 | Mar 19, 2026 | - | - | - |
| 4 | Mar 19, 2026 | - | - | - |
| 4 | Mar 19, 2026 | - | - | - |
| 4 | Mar 2, 2026 | - | - | - |
| 4 | Feb 26, 2026 | - | - | - |
| 4 | Feb 17, 2026 | - | - | |
| 10-Q | Feb 6, 2026 | Dec 31, 2025 | Analysis | |
| 4 | Nov 24, 2025 | - | - | |
| 10-Q | Nov 6, 2025 | Sep 30, 2025 | Analysis | |
| 10-K | Sep 15, 2025 | Jun 30, 2025 | Analysis | |
| 10-Q | May 9, 2025 | Mar 31, 2025 | - | |
| 10-Q | Feb 7, 2025 | Dec 31, 2024 | - | |
| 10-Q | Nov 12, 2024 | Sep 30, 2024 | - | |
| 10-K | Sep 27, 2024 | Jun 30, 2024 | - | |
| SC 13G | Jul 12, 2024 | - | - |
Related Consumer Staples companies
- MO · AltriaCigarettes
- PM · Philip Morris InternationalCigarettes
- ACI · Albertsons Companies IncRetail-Grocery Stores
- ANDE · Andersons, Inc.Wholesale-Farm Product Raw Materials
- BUD · Anheuser-Busch InBev SA/NVMalt Beverages
- ADM · Archer Daniels MidlandFats & Oils
- ARKO · ARKO Corp.Retail-Convenience Stores
- BGS · B&G Foods, Inc.Food and Kindred Products
ISPR SEC filings: frequently asked questions
Which institutions hold ISPR stock?
As of June 30, 2026, the largest Ispire Technology Inc. (ISPR) holders among the 13F filers tracked by SignalX were BlackRock ($459,000), Millennium Management ($291,000), Vanguard Capital Management LLC ($221,000), Goldman Sachs Group ($161,000), AQR Capital Management ($118,000). 13F-HR reports are filed up to 45 days after each quarter ends.
What was ISPR's revenue in fiscal year 2026?
For the fiscal year ended June 30, 2026 (FY2026), Ispire Technology Inc. (ISPR) reported revenue of $96.0 million (down 24.7% from FY2025) and a net loss of $33.2 million. Diluted EPS was -$0.58. The figures come from the XBRL data in the 10-K.
What are the main risks in ISPR's latest 10-K?
In the 10-K filed September 15, 2026, Ispire Technology Inc. (ISPR) flagged: Regulatory risk: FDA PMTA compliance and enforcement for nicotine ENDS under Family Smoking Prevention and Tobacco Control Act; costly $1M+ per PMTA application. Geopolitical risk: U.S. tariffs on Chinese imports at 35% and Malaysian imports at 19%, affecting Shenzhen Yi Jia product costs, a major supplier. (AI summary of the Risk Factors section.)
What did ISPR report in its latest 8-K?
Ispire Technology Inc. (ISPR) filed an 8-K on September 23, 2026 reporting Item 7.01 (Regulation FD Disclosure). Exhibit 99.1 excluded from Exchange Act Section 18 “filed” status, limiting liability exposure.
What are the latest ISPR SEC filings?
Ispire Technology Inc. (ISPR) filed its latest 10-K annual report on September 15, 2026, a 10-Q quarterly report on May 7, 2026, an 8-K current report on September 23, 2026 and a Form 4 insider filing on August 14, 2026.
What is ISPR's SEC CIK number?
Ispire Technology Inc. (ISPR)'s SEC Central Index Key (CIK) is 1948455. EDGAR lists every ISPR filing under that number.
Ask anything about ISPR
The research agent reads ISPR's filings, financials, insider trades and 13F holders, then answers with sources.